122 related articles for article (PubMed ID: 1619518)
41. Developments in radiotherapy other than heavy particle beams.
Fowler JF
Int J Radiat Oncol Biol Phys; 1977; 3():351-8. PubMed ID: 207661
[No Abstract] [Full Text] [Related]
42. [Experimental chemotherapy of human breast carcinomas transplanted into nude mice].
Koh J; Asanuma F; Kurihara H; Konno H; Kubouchi K; Ikeda T; Enomoto K; Ishibiki K; Abe O; Kubota T
Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1488-95. PubMed ID: 6440935
[No Abstract] [Full Text] [Related]
43. Anginex synergizes with radiation therapy to inhibit tumor growth by radiosensitizing endothelial cells.
Dings RP; Williams BW; Song CW; Griffioen AW; Mayo KH; Griffin RJ
Int J Cancer; 2005 Jun; 115(2):312-9. PubMed ID: 15688384
[TBL] [Abstract][Full Text] [Related]
44. O02.03 Value of adding erlotinib to thoracic radiation therapy with chemotherapy for stage III non-small cell lung cancer: a prospective phase II study.
Clin Adv Hematol Oncol; 2014 Jan; 12(1 Suppl 1):6. PubMed ID: 24852396
[No Abstract] [Full Text] [Related]
45. Laser dyes for experimental phototherapy of human cancer: comparison of three rhodamines.
Haghighat S; Castro DJ; Lufkin RB; Fetterman HR; Castro DJ; Soudant J; Ward PH; Saxton RE
Laryngoscope; 1992 Jan; 102(1):81-7. PubMed ID: 1731162
[TBL] [Abstract][Full Text] [Related]
46. Tumor treatment by sustained intratumoral release of 5-fluorouracil: effects of drug alone and in combined treatments.
Berrada M; Yang Z; Lehnert S
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1550-7. PubMed ID: 12459384
[TBL] [Abstract][Full Text] [Related]
47. Combination of S-1 and gefitinib increases the sensitivity to radiotherapy in lung cancer cells.
Cui J; Wang MC; Zhang YM; Ren MZ; Wang SX; Nan KJ; Song LP
Cancer Chemother Pharmacol; 2018 Apr; 81(4):717-726. PubMed ID: 29480364
[TBL] [Abstract][Full Text] [Related]
48. Fractionated treatment of CaD2 tumors in mice sensitized with aluminium phthlocyanine tetrasulfonate.
Anholt H; Moan J
Cancer Lett; 1992 Jan; 61(3):263-7. PubMed ID: 1739951
[TBL] [Abstract][Full Text] [Related]
49. Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
Rockwell S
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1631-4. PubMed ID: 6434497
[TBL] [Abstract][Full Text] [Related]
50. Concurrent chemoradiation for cervical cancer: what should we do next?
Toita T
Int J Clin Oncol; 2006 Aug; 11(4):253-5. PubMed ID: 16937297
[No Abstract] [Full Text] [Related]
51. The synergistic effects of rhodamine-123 and merocyanine-540 laser dyes on human tumor cell lines: a new approach to laser phototherapy.
Castro DJ; Saxton RE; Haghighat S; Reisler E; Plant D; Soudant J
Otolaryngol Head Neck Surg; 1993 Mar; 108(3):233-42. PubMed ID: 8464635
[TBL] [Abstract][Full Text] [Related]
52. [Present status of radiotherapy of malignant tumors and basic trends in its development].
Pereslegin IA; Zolotkov AG
Vestn Rentgenol Radiol; 1983; (6):5-10. PubMed ID: 6429926
[No Abstract] [Full Text] [Related]
53. Comparison of low dose nicotinamide versus benzamide, administered per os, as radiosensitizers in a C3H mammary carcinoma.
Kjellen E; Pero RW; Nilsson P
Radiother Oncol; 1988 Aug; 12(4):327-31. PubMed ID: 2973086
[TBL] [Abstract][Full Text] [Related]
54. Cancer chemotherapy: past is prologue.
Martin DS
Mt Sinai J Med; 1985 Jun; 52(6):426-34. PubMed ID: 3875021
[No Abstract] [Full Text] [Related]
55. Chemotherapy as an adjuvant to cystectomy and for advanced urothelial cancer.
Loening S
Urol Clin North Am; 1984 Nov; 11(4):699-708. PubMed ID: 6390915
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of chemotherapy and radiation enhancement and 31P NMR spectral changes induced by biochemical modulation.
Koutcher JA; Alfieri AA; Tsai JC; Matei C; Stolfi RL; Ballon D; Martin DS
Cancer Invest; 1997; 15(2):111-20. PubMed ID: 9095206
[TBL] [Abstract][Full Text] [Related]
57. Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells.
Shea CR; Chen N; Wimberly J; Hasan T
Cancer Res; 1989 Jul; 49(14):3961-5. PubMed ID: 2736534
[TBL] [Abstract][Full Text] [Related]
58. Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors.
Van den Brande J; Nannan Panday VR; Hoekman K; Rosing H; Huijskes RV; Verheijen RH; Beijnen JH; Vermorken JB
Am J Clin Oncol; 2001 Aug; 24(4):401-3. PubMed ID: 11474273
[TBL] [Abstract][Full Text] [Related]
59. Assessment of antitumor (antimetastatic) efficacy of cytotoxic agents.
Milas L; Tofilon PJ; Brock WA
Prog Clin Biol Res; 1986; 212():305-21. PubMed ID: 3520579
[No Abstract] [Full Text] [Related]
60. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors.
Rockwell S; Schulz RJ
Radiat Res; 1984 Dec; 100(3):527-35. PubMed ID: 6505142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
